BioMarin Pharmaceutical Inc. – Strategy, SWOT, and Corporate Finance Report – Market Research Report
Aarkstore.com announce a new report through its vast collection of market research report :
BioMarin Pharmaceutical Inc. – Strategy, SWOT, and Corporate Finance Report
For some-more information, Great fully visit:
http://www.aarkstore.com/reports/BioMarin-Pharmaceutical-Inc-Strategy-SWOT-and-Corporate-Finance-Report-156170.html
BioMarin Pharmaceutical Inc. – SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Features:
– Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
– A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
– An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
– Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for BioMarin Pharmaceutical Inc.
– Intelligence on BioMarin Pharmaceutical Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
– News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
– Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market. The company primarily operates in the US. It is headquartered in Novato, California and employed 720 people as of February 2010. The company recorded revenues of $324.7 million during the financial year (FY) ended December 2009, an increase of 9.5% over FY2008. The increase in revenues was due to the increased Naglazyme and Kuvan sales. The operating profit of the company was $16.4 million during FY2009, a decrease of 58.7% over FY2008. The net loss of the company was $0.5 million in FY2009, as compared to the net profit of $30.8 million in FY2008.
Reasons to Purchase:
– Gain understanding of the BioMarin Pharmaceutical Inc. and the factors that influence its strategies
– Track strategic initiatives of the company and latest corporate news and actions
– Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
– Support sales activities by understanding your customers businesses better
– Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects
Table of Contents :
Company Snapshot
BioMarin Pharmaceutical Inc.: Company Overview
BioMarin Pharmaceutical Inc.: Overview and Key Facts
BioMarin Pharmaceutical Inc.: Overview
BioMarin Pharmaceutical Inc.: Key Facts
BioMarin Pharmaceutical Inc.: Key Employees
BioMarin Pharmaceutical Inc.: Key Employee Biographies
BioMarin Pharmaceutical Inc.: Major Products and Services
BioMarin Pharmaceutical Inc.: Company History
BioMarin Pharmaceutical Inc.: Management Statement
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
BioMarin Pharmaceutical Inc.: Key Competitors
BioMarin Pharmaceutical Inc.: Company Analysis
BioMarin Pharmaceutical Inc.: Business Description
BioMarin Pharmaceutical Inc.: SWOT Analysis
BioMarin Pharmaceutical Inc.: SWOT Overview
BioMarin Pharmaceutical Inc.: Strengths
BioMarin Pharmaceutical Inc.: Weaknesses
BioMarin Pharmaceutical Inc.: Opportunities
BioMarin Pharmaceutical Inc.: Threats
BioMarin Pharmaceutical Inc.: Financial Analysis
BioMarin Pharmaceutical Inc.: Financial Overview
BioMarin Pharmaceutical Inc.: Five Year Company Financials
BioMarin Pharmaceutical Inc.: Key Income Statement Data
BioMarin Pharmaceutical Inc.: Key Balance Sheet Data
BioMarin Pharmaceutical Inc.: Key Cash Flow Data
BioMarin Pharmaceutical Inc.: Key Market Data
BioMarin Pharmaceutical Inc.: Valuation Ratios
BioMarin Pharmaceutical Inc.: Profitability Ratios
BioMarin Pharmaceutical Inc.: Management Efficiency Ratios
BioMarin Pharmaceutical Inc.: Financial Strength Ratios
BioMarin Pharmaceutical Inc.: Operational Efficiency Ratios
BioMarin Pharmaceutical Inc.: Others
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
BioMarin Pharmaceutical Inc.: Financial Deals Overview
BioMarin Pharmaceutical Inc.: Targets and Partners
BioMarin Pharmaceutical Inc.: Top Deals 2007 -YTD*2011
BioMarin Pharmaceutical Inc.: Advisors
BioMarin Pharmaceutical Inc.: Top Legal Advisors
BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
BioMarin Pharmaceutical Inc.: Corporate Venturing
BioMarin Pharmaceutical Inc.: Partnership
BioMarin Pharmaceutical Inc.: Recent Developments
BioMarin Pharmaceutical Inc.: News and Events Summary
BioMarin Pharmaceutical Inc.: Contracts
BioMarin Pharmaceutical Inc.: Corporate Governance
BioMarin Pharmaceutical Inc.: Financial Deals
BioMarin Pharmaceutical Inc.: Financial Performance
BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
BioMarin Pharmaceutical Inc.: Research & Development
BioMarin Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Company
Processing your request, Please wait....
